United States Neuromodulation Devices and Implantable Infusion Pumps Market by Manufacturers, Type and Application, Forecast to 2021

Key driving factors in this market are aging population and chronic diseases. Aging Population: Past few decades have recorded a steeping rise in the population of aging people. Growing number of aging people is directly associated with health issues related with nerves and their activity level. Timely intervention in this activity is becoming essential. Elderly suffering from movement disorders, chronic pain, cardiovascular disorders and other age-related issues are driving the industry. Varied applications of the neurostimulation procedures have vital impact on the global market.

Scope of the Report:
This report focuses on the Neuromodulation Devices and Implantable Infusion Pumps in United States market. This report categorizes the market based on manufacturers, type and application.
Market Segment by Manufacturers, this report covers
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical

Market Segment by Type, covers
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other

Market Segment by Applications, can be divided into
Parkinson's disease
Epilepsy
Pain
Other

There are 11 Chapters to deeply display the United States Neuromodulation Devices and Implantable Infusion Pumps market.

Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with sales, revenue, and price of Neuromodulation Devices and Implantable Infusion Pumps, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4 and 5, to show the market of Neuromodulation Devices and Implantable Infusion Pumps by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 6, Neuromodulation Devices and Implantable Infusion Pumps market forecast, by type and application, with sales and revenue, from 2016 to 2021;

Chapter 7, to analyze the Neuromodulation Devices and Implantable Infusion Pumps market development potential except United States, covering China, Southeast Asia, India, Latin America etc.

Chapter 8, 9, 10 and 11, to describe sales channel, distributors, traders, dealers, market effect factors, appendix and data source.

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports